Publications by authors named "Jia-Hui Shan"
BMC Cancer
September 2022
Article Synopsis
- The study compared the effectiveness and safety of various immune checkpoint inhibitors for treating advanced or metastatic esophageal squamous cell carcinoma (ESCC).
- A systematic review included ten trials with 5250 patients, using Bayesian network meta-analysis to evaluate overall survival and progression-free survival among different treatments.
- The findings indicated that Toripalimab and Camrelizumab with chemotherapy were the most effective first-line treatment options, while Sintilimab and Camrelizumab showed promise for patients with refractory cases, with manageable toxicity levels.
